| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 7.838 | 6.065 | 1.217 | 10.108 | 0 |
| Total Income - EUR | - | - | - | - | - | 7.838 | 6.065 | 1.217 | 10.108 | 0 |
| Total Expenses - EUR | - | - | - | - | - | 2.998 | 495 | 595 | 391 | 216 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 4.840 | 5.569 | 622 | 9.717 | -216 |
| Net Profit/Loss - EUR | - | - | - | - | - | 4.676 | 5.424 | 586 | 9.717 | -216 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Fipas Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 7.075 | 7.097 | 7.076 | 7.036 |
| Current Assets | - | - | - | - | - | 4.848 | 2.961 | 3.565 | 13.271 | 11.476 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 128 | 0 | 36 | 0 |
| Cash | - | - | - | - | - | 4.848 | 2.833 | 3.565 | 13.235 | 11.476 |
| Shareholders Funds | - | - | - | - | - | 4.717 | 10.036 | 10.654 | 20.338 | 18.504 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 131 | 0 | 8 | 8 | 8 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Fipas Med S.r.l.